10.32
10.32 (0%)
As of Feb 14, 2025
Keros Therapeutics, Inc. [KROS]
Source:
Company Overview
Keros Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta, or TGF- , family of proteins. We are a leader in understanding the role of the TGF- family of proteins, which are master regulators of the growth, repair and maintenance of a number of tissues, including blood, bone, skeletal muscle, adipose and heart tissue.
Country | United States |
Headquarters | lexington, massachusetts |
Phone Number | 617-314-6297 |
Industry | manufacturing |
CEO | Jasbir Seehra, Ph.D. |
Website | www.clinicaltrials.gov |